लोड हो रहा है...
Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab
BACKGROUND: Preliminary evidence indicates that early tumor shrinkage (ETS) following immune checkpoint inhibitor (ICI) initiation may be associated with survival outcomes in patients with advanced melanoma. ETS has not been explored as a biomarker of survival outcomes or patient-reported outcomes i...
में बचाया:
| में प्रकाशित: | J Immunother Cancer |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMJ Publishing Group
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279663/ https://ncbi.nlm.nih.gov/pubmed/32503948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000500 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|